<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">Fungi are excellent sources of bioactive metabolites, possessing antiviral properties (
 <xref rid="t0015" ref-type="table">Table 3</xref> ). The first antiviral metabolite from fungi 
 <italic>Stachybotrys</italic> sp. was tested against H1N1 Influenza virus (
 <xref rid="bb0970" ref-type="bibr">Moghadamtousi et al., 2015</xref>). Compounds isolated from 
 <italic>Penicillium</italic> sp. were tested for antiviral properties. Trypilepyrazinol acted as an inhibitor against HIV-1 and HCV. (+)-neocitreoviridin showed anti-influenza A virus activity. 3-Î²-hydroxyergosta-8,14,24(28)-trien-7-one expressed anti-HIV and anti-influenza A activities (
 <xref rid="bb0820" ref-type="bibr">Li et al., 2019</xref>). Fungi associated compounds such as physcion, neoechinulin D, and dihydroauroglaucin inhibited replication of Influenza A virus (
 <xref rid="bb0165" ref-type="bibr">Bovio et al., 2019</xref>).
</p>
